查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2024 年呼吸吸入裝置全球市場報告
市場調查報告書
商品編碼
1415761

2024 年呼吸吸入裝置全球市場報告

Respiratory Inhaler Devices Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，呼吸吸入器市場規模一直強勁成長。將從2023年的385.4億美元成長到2024年的413.5億美元，複合年成長率為7.3%。實際期間的成長是由於吸煙流行、過敏性疾病、藥物創新和人口老化等因素造成的。

呼吸吸入器市場規模預計在未來幾年將強勁成長。 2028年，將以7.3%的複合年成長率成長至547.2億美元。預測期內的成長可歸因於空氣品質問題、數位健康整合、對吸入器安全的監管重視以及個人化治療。預測期內的主要趨勢包括吸入器設備的小型化、永續性和環境友善吸入器、居家照護和技術進步。

呼吸系統疾病的盛行率正在上升，這一現象推動了呼吸吸入設備市場的成長。呼吸系統疾病包括影響肺部和呼吸系統的多種疾病，常常導致呼吸困難和肺功能下降。這些疾病包括氣喘、慢性阻塞性肺病（COPD）、呼吸道融合細胞病毒感染疾病、以及各種其他呼吸道疾病。使用呼吸吸入裝置對於將藥物直接輸送到肺部並為患有呼吸道疾病的人提供快速、準確的緩解至關重要。例如，美國著名公共衛生組織疾病管制與預防中心的最新資料顯示，美國報告的結核病病例數較2021年的7874例有所增加。到 2022 年，病例數將達到 8,300 例。此資料凸顯了呼吸系統疾病盛行率不斷上升推動呼吸吸入裝置市場擴張的主要驅動力。

吸煙率的快速上升預計將成為呼吸吸入器市場成長的主要促進因素。吸煙是吸入和呼出植物燃燒時產生的蒸氣，其中煙草是最常見的罪魁禍首。吸菸會對氣道和肺部的小氣囊（稱為肺泡）造成嚴重損害，進而導致氣喘、慢性阻塞性肺病和支氣管炎等肺部疾病的發生。在這種情況下，呼吸吸入裝置是緩解和預防吸煙相關問題引起的呼吸窘迫的重要工具。令人擔憂的是，根據美國疾病管制與預防中心的報告，到 2021 年，美國約有 11.5% 的成年人（估計有 2,830 萬人）是吸菸者。結果，超過 1600 萬美國人正在與吸煙引起的疾病作鬥爭。因此，吸煙率的上升是推動呼吸吸入器市場的強大力量。

2023年，北美是呼吸吸入器市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。呼吸吸入器報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美、中東和非洲。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與抑制因素
    • 市場促進因素
    • 市場抑制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長，2023-2028、2033

第6章市場區隔

  • 全球呼吸吸入器市場，依產品、性能及預測細分，2018-2023、2023-2028、2033
  • 乾粉吸入器
  • 定量吸入器
  • 噴霧器
  • 全球呼吸吸入器市場，按技術、性能和預測細分，2018-2023、2023-2028、2033
  • 手動吸入器
  • 數位操作吸入器
  • 全球呼吸吸入器市場，依疾病適應症、績效及預測細分，2018-2023、2023-2028、2033
  • 氣喘
  • 慢性阻塞性肺病
  • 肺動脈高血壓
  • 其他適應症
  • 全球呼吸吸入器市場，按最終用戶細分、績效和預測，2018-2023、2023-2028、2033
  • 醫院和診所
  • 呼吸護理中心
  • 其他最終用戶

第 7 章 區域與國家分析

  • 全球呼吸吸入器市場，按地區、業績和預測，2018-2023、2023-2028、2033
  • 全球呼吸吸入器市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 呼吸吸入器市場競爭形勢
  • 呼吸吸入裝置市場公司概況
    • Merck &Co. Inc.
    • Novartis AG
    • AstraZeneca plc
    • Gerresheimer AG
    • GlaxoSmithKline plc

第31章 其他重大及創新企業

  • 3M
  • Boehringer Ingelheim International GmbH
  • Koninklijke Philips NV
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Catalent Inc.
  • Perrigo Company plc
  • AptarGroup Inc.
  • Recipharm AB
  • Chiesi Farmaceutici SpA
  • Cipla Limited
  • Hikma Pharmaceuticals plc
  • Zydus Lifesciences Limited
  • Lupin Limited
  • Glenmark Pharmaceuticals Ltd.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r12360

“Respiratory Inhaler Devices Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory inhaler devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory inhaler devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The respiratory inhaler devices market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
  • 2) By Technology: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
  • 3) By Disease Indication: Asthma; Chronic Obstructive Pulmonary Disease; Pulmonary Arterial Hypertension; Other Indications
  • 4) By End User: Hospitals And Clinics; Respiratory Care Centers; Other End Users
  • Companies Mentioned: Merck & Co. Inc.; Novartis AG; AstraZeneca plc; Gerresheimer AG; GlaxoSmithKline plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Respiratory inhaler devices are compact, handheld tools designed to administer medication directly to the lungs. They are specifically engineered to deliver medications to the respiratory system, with a focus on the lungs, which helps minimize systemic drug effects and provides rapid relief during respiratory attacks or exacerbations.

The primary categories of respiratory inhaler device products include dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers (DPIs) are medical devices that dispense powdered medications directly to the lungs for the treatment of respiratory conditions. These inhaler devices encompass both manually operated and digitally operated options. They are commonly used in the management of conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension, and other respiratory issues. Respiratory inhaler devices find application in various healthcare settings, including hospitals, clinics, respiratory care centers, and other medical facilities. They serve as important tools for the delivery of respiratory medications and the management of respiratory conditions.

The respiratory inhaler devices market research report is one of a series of new reports from The Business Research Company that provides respiratory inhaler devices market statistics, including respiratory inhaler devices industry global market size, regional shares, competitors with a respiratory inhaler devices market share, detailed respiratory inhaler devices market segments, market trends and opportunities and any further data you may need to thrive in the respiratory inhaler devices industry. This respiratory inhaler devices market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The respiratory inhaler devices market size has grown strongly in recent years. It will grow from $38.54 billion in 2023 to $41.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to smoking epidemic, allergic disorders, pharmaceutical innovation, aging population.

The respiratory inhaler devices market size is expected to see strong growth in the next few years. It will grow to $54.72 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to air quality concerns, digital health integration, regulatory emphasis on inhaler safety, personalized treatment. Major trends in the forecast period include inhaler device miniaturization, sustainability and eco-friendly inhalers, home-based care, technological advancements.

The prevalence of respiratory diseases is on the rise, and this phenomenon is poised to steer the growth of the respiratory inhaler devices market. Respiratory diseases encompass a spectrum of disorders that affect the lungs and the respiratory system, often resulting in breathing difficulties and compromised lung function. These conditions include ailments like asthma, chronic obstructive pulmonary disease (COPD), respiratory syncytial virus infection, and various other respiratory disorders. The utilization of respiratory inhaler devices is essential in delivering medications directly to the lungs, providing swift and precise relief for individuals battling respiratory illnesses. As an example, recent data from the Centers for Disease Control and Prevention, a prominent US-based public health organization, revealed an increase in tuberculosis (TB) cases reported in the United States, reaching 8,300 cases in 2022, up from 7,874 cases in 2021. This data underscores the significant impetus resulting from the growing prevalence of respiratory diseases, which propels the expansion of the respiratory inhaler devices market.

The burgeoning rates of smoking are anticipated to be a key driver in the growth of the respiratory inhaler devices market. Smoking entails the inhalation and exhalation of vapors generated from the combustion of plant substances, with tobacco being the most common source. Smoking has the potential to inflict substantial damage to the airways and the tiny lung air sacs, known as alveoli, potentially leading to the development of lung diseases such as asthma, COPD, and bronchitis. In this context, respiratory inhaler devices serve as indispensable tools in mitigating and preventing respiratory distress caused by smoking-related issues. Remarkably, the Centers for Disease Control and Prevention reported that nearly 11.5% of adults in the United States, representing an estimated 28.3 million individuals, were smokers in 2021. Consequently, more than 16 million Americans grapple with ailments stemming from smoking. Hence, the upsurge in smoking rates is a potent force propelling the respiratory inhaler devices market.

The primary obstacle facing the respiratory inhaler devices market during the projected period is the lack of patient adherence to prescribed medications. Non-adherence to prescribed treatments can lead to suboptimal inhalation therapy outcomes and a subsequent increase in healthcare costs. This issue encompasses patients who may not adhere to their prescribed medication regimens, a behavior that is notably prevalent among individuals managing chronic conditions with substantial health implications. Illustratively, data from April 2022, sourced from the American Journal of Managed Care, revealed that approximately 50% of individuals failed to follow the prescribed treatment plan for their chronic, long-term medications. Poor adherence contributes to over $500 billion in avoidable healthcare expenditures annually, potentially preventable fatalities numbering over 125,000, and up to 25% of hospitalizations in the United States. Consequently, the lack of patient adherence to prescribed medications serves as a significant constraint in the growth of the respiratory inhaler devices market.

Prominent companies within the respiratory inhaler devices market are increasingly adopting advanced technologies, such as metered dosage inhalers (MDIs), to fortify their market standing. MDIs represent portable aerosol devices designed to deliver precise medication doses to the lungs in the form of an inhaled mist or spray. For instance, a noteworthy development occurred in February 2022, when AptarGroup Inc., a US-based manufacturer specializing in consumer dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This innovative digital respiratory health solution effectively transforms conventional metered dosage inhalers (pMDIs) into intelligent and connected medical devices. HeroTracker Sense aims to monitor the utilization of MDIs by patients, promoting better adherence to prescribed therapies and ultimately enhancing the lives of individuals worldwide grappling with chronic respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and respiratory complications triggered by COVID-19. HeroTracker Sense further offers invaluable analytics and insights related to patient training, onboarding, and performance, serving healthcare providers (HCPs) through the Aptar Pharma Cohero Health BreatheSmart Connect portal.

In August 2022, AptarGroup Inc., a US-based manufacturer specializing in consumer dispensing packaging and drug delivery devices, secured the global rights to the Orbital inhaler through an acquisition from Pharmaxis Ltd. This strategic acquisition of the Orbital inhaler rights aligns with Aptar Pharma's mission to expand its respiratory device portfolio and provide innovative solutions catering to patients grappling with respiratory conditions. Pharmaxis Ltd., an Australian-based pharmaceutical company with a clinical-stage focus, developed the groundbreaking Orbital dry powder inhaler. This strategic acquisition demonstrates a commitment to advancing respiratory care.

Major players in the respiratory inhaler devices market are Merck & Co. Inc., Novartis AG, AstraZeneca PLC, Gerresheimer AG, GlaxoSmithKline PLC, 3M, Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., Perrigo Company PLC, AptarGroup Inc., Recipharm AB, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Orion Corporation, Sumitomo Pharma America Inc., Beximco Pharmaceuticals Ltd., Hovione Limited, Vectura Group Limited, H&T Presspart Manufacturing Ltd., Pari Medical Holding GmbH, OMRON Healthcare Europe B.V., Medisol Lifescience Pvt. Ltd., Consort Medical plc .

North America was the largest region in the respiratory inhaler devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory inhaler devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the respiratory inhaler devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The respiratory inhaler devices market consists of revenues earned by entities by providing services such as the management of chronic lung diseases and minimizing systemic effects of the drugs. The market value includes the value of related goods sold by the service provider or included within the service offering. The respiratory inhaler devices market also includes sales of compressed air nebulizers, ultrasonic nebulizers and mesh nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Respiratory Inhaler Devices Market Characteristics

3. Respiratory Inhaler Devices Market Trends And Strategies

4. Respiratory Inhaler Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Respiratory Inhaler Devices Market Size and Growth

  • 5.1. Global Respiratory Inhaler Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Respiratory Inhaler Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Respiratory Inhaler Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Respiratory Inhaler Devices Market Segmentation

  • 6.1. Global Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Nebulizers
  • 6.2. Global Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices
  • 6.3. Global Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Other Indications
  • 6.4. Global Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Respiratory Care Centers
  • Other End Users

7. Respiratory Inhaler Devices Market Regional And Country Analysis

  • 7.1. Global Respiratory Inhaler Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Respiratory Inhaler Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Respiratory Inhaler Devices Market

  • 8.1. Asia-Pacific Respiratory Inhaler Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Respiratory Inhaler Devices Market

  • 9.1. China Respiratory Inhaler Devices Market Overview
  • 9.2. China Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Respiratory Inhaler Devices Market

  • 10.1. India Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Respiratory Inhaler Devices Market

  • 11.1. Japan Respiratory Inhaler Devices Market Overview
  • 11.2. Japan Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Respiratory Inhaler Devices Market

  • 12.1. Australia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Respiratory Inhaler Devices Market

  • 13.1. Indonesia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Respiratory Inhaler Devices Market

  • 14.1. South Korea Respiratory Inhaler Devices Market Overview
  • 14.2. South Korea Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Respiratory Inhaler Devices Market

  • 15.1. Western Europe Respiratory Inhaler Devices Market Overview
  • 15.2. Western Europe Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Respiratory Inhaler Devices Market

  • 16.1. UK Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Respiratory Inhaler Devices Market

  • 17.1. Germany Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Respiratory Inhaler Devices Market

  • 18.1. France Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Respiratory Inhaler Devices Market

  • 19.1. Italy Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Respiratory Inhaler Devices Market

  • 20.1. Spain Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Respiratory Inhaler Devices Market

  • 21.1. Eastern Europe Respiratory Inhaler Devices Market Overview
  • 21.2. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Respiratory Inhaler Devices Market

  • 22.1. Russia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Respiratory Inhaler Devices Market

  • 23.1. North America Respiratory Inhaler Devices Market Overview
  • 23.2. North America Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Respiratory Inhaler Devices Market

  • 24.1. USA Respiratory Inhaler Devices Market Overview
  • 24.2. USA Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Respiratory Inhaler Devices Market

  • 25.1. Canada Respiratory Inhaler Devices Market Overview
  • 25.2. Canada Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Respiratory Inhaler Devices Market

  • 26.1. South America Respiratory Inhaler Devices Market Overview
  • 26.2. South America Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Respiratory Inhaler Devices Market

  • 27.1. Brazil Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Respiratory Inhaler Devices Market

  • 28.1. Middle East Respiratory Inhaler Devices Market Overview
  • 28.2. Middle East Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Respiratory Inhaler Devices Market

  • 29.1. Africa Respiratory Inhaler Devices Market Overview
  • 29.2. Africa Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Respiratory Inhaler Devices Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Inhaler Devices Market Competitive Landscape
  • 30.2. Respiratory Inhaler Devices Market Company Profiles
    • 30.2.1. Merck & Co. Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novartis AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AstraZeneca plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Gerresheimer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GlaxoSmithKline plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Respiratory Inhaler Devices Market Other Major And Innovative Companies

  • 31.1. 3M
  • 31.2. Boehringer Ingelheim International GmbH
  • 31.3. Koninklijke Philips N.V.
  • 31.4. Viatris Inc.
  • 31.5. Teva Pharmaceutical Industries Ltd.
  • 31.6. Catalent Inc.
  • 31.7. Perrigo Company plc
  • 31.8. AptarGroup Inc.
  • 31.9. Recipharm AB
  • 31.10. Chiesi Farmaceutici S.p.A.
  • 31.11. Cipla Limited
  • 31.12. Hikma Pharmaceuticals plc
  • 31.13. Zydus Lifesciences Limited
  • 31.14. Lupin Limited
  • 31.15. Glenmark Pharmaceuticals Ltd.

32. Global Respiratory Inhaler Devices Market Competitive Benchmarking

33. Global Respiratory Inhaler Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Respiratory Inhaler Devices Market

35. Respiratory Inhaler Devices Market Future Outlook and Potential Analysis

  • 35.1 Respiratory Inhaler Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Respiratory Inhaler Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Respiratory Inhaler Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer